BIO-EUROPE 

October 26-29, 2020 (only in digital form)

For more than 25 years BIO-Europe has played an instrumental role in bringing biopharma and investment leaders together, to facilitate innovation and medical breakthroughs.

Last year more than 26,000 one-to-one meetings were facilitated using our proprietary platform, partneringONE®. Additionally, the event features pitches from biotech companies and academic innovators as well as insights from industry leaders in sessions and fireside chats.

The 26th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe, though in 2020 by necessity we have gone fully digital and expanded the format to four 24-hour days to accommodate partnering meetings all over the world.

Over 4,400 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners.

BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization (BIO).

For more information and online registration please visit the Bio-Europe website.

Your U.S. Commercial Service Contact:

The U.S. Commercial Service Global Healthcare Team stands ready to assist interested U.S. companies to connect to the European biotech industry, and international firms to get in touch with U.S. firms, research institutions and suppliers. If you are interested in further information and to connect during Bio-Europe, please contact:

Sabine Winkels, Commercial Specialist, Biotechnology
U.S. Commercial Service Germany
Phone: +49 (0) 211 – 737 767 40
Email: Sabine.Winkels@trade.gov